Retrospective analysis demonstrates improved clinical efficacy in bortezomib-induced peripheral neuropathy using combined therapies, suggesting a safe treatment option.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
XU et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: